# Future Work

This page documents planned enhancements and remaining implementation work for the T1D Exchange FHIR Implementation Guide based on comprehensive gap analysis of the T1D Exchange specifications.

## Gap Analysis Summary

**Current Implementation Coverage:**
- **Variables**: 9.2% (14 of 153 variables implemented)
- **Coded Values**: 34.2% (140 of 409 coded values implemented)

## Planned Enhancements

### Phase 1: High-Priority Variables (In Progress)
- Core identifiers: organization_id, encounter_id refinements
- Demographics: postal_code, date_of_death, cause_of_death
- Clinical data: T1D diagnosis date precision, hypoglycemia events, DKA episodes
- Device data: insulin pump models, CGM usage patterns, BGM frequency tracking

### Phase 2: Comprehensive Analysis Report
- **Detailed Mapping Document**: Complete spec-to-FHIR element relationship mapping
- **Implementation Roadmap**: Priority-based implementation sequence with effort estimates
- **Design Decision Documentation**: Rationale for unmapped variables and alternative approaches
- **Validation Framework**: Testing approach for specification compliance

### Phase 3: Automated Profile Enhancement
- **Missing Must Support Elements**: Script-based addition of specification-required elements
- **ValueSet Generation**: Automated creation of missing coded value sets from extracted data
- **Profile Metadata Enhancement**: Integration of specification definitions, priorities, and implementation notes
- **Continuous Validation**: Automated gap analysis for ongoing specification alignment

## Missing High-Priority Elements

### Core Demographics
- Postal code tracking for population health analysis
- Death date and cause of death for longitudinal studies
- Enhanced race/ethnicity capture (race_1, race_2 fields)

### Clinical Data Gaps
- Severe hypoglycemia event tracking (ambulatory vs inpatient)
- DKA episode documentation with laboratory values
- Hypoglycemia awareness assessment
- Care transition planning documentation

### Device Integration
- Comprehensive insulin pump manufacturer and model tracking
- CGM usage patterns and sensor change frequency
- Blood glucose meter testing frequency and methods
- Device data review and patient engagement metrics

### Social Determinants
- Transportation insecurity screening
- Housing insecurity assessment
- Food insecurity evaluation (Hunger Vital Signs)

## Technical Implementation Tasks

### ValueSet Expansion
- **Device Manufacturers**: 50+ insulin pump, CGM, and BGM manufacturer codes
- **Clinical Assessments**: Hypoglycemia awareness, transition planning status codes
- **SDOH Screening**: Transportation, housing, food insecurity response codes
- **Encounter Types**: T1D-specific encounter classifications and reasons

### Profile Enhancements
- **T1DPatient**: Add postal code, death information, enhanced demographics
- **T1DCondition**: Add T1D diagnosis date precision and transition planning
- **T1DObservation**: Expand for hypoglycemia events, DKA episodes, SDOH screening
- **T1DEncounter**: Add T1D-specific encounter types and endocrinology visit tracking

### Bundle Pattern Extensions
- **Quality Reporting**: Enhanced metrics for T1D Exchange collaborative reporting
- **Device Data Integration**: Patterns for insulin pump, CGM, and BGM data submission
- **Population Health**: Aggregated data patterns for registry and research use

## Implementation Priorities

### Immediate (Next Release)
1. Core identifier refinements
2. High-priority demographic elements
3. Essential clinical data gaps
4. Critical device tracking elements

### Short-term (6 months)
1. Complete SDOH screening integration
2. Comprehensive device manufacturer ValueSets
3. Enhanced quality metrics support
4. Automated gap analysis tooling

### Long-term (12+ months)
1. Real-time device data integration patterns
2. Advanced population health analytics support
3. Machine learning-ready data structures
4. International terminology alignment

## Validation and Testing

### Specification Compliance
- Automated testing against T1D Exchange data requirements
- Validation of priority level implementation completeness
- Cross-reference verification with original Excel specifications

### Interoperability Testing
- FHIR R4 compliance validation
- Bundle pattern testing with sample data
- Terminology binding verification
- Example instance validation

### Clinical Workflow Integration
- Epic-specific implementation guidance validation
- Provider workflow impact assessment
- Patient data submission pattern testing
- Quality reporting metric calculation verification

## Community Engagement

### Stakeholder Feedback
- T1D Exchange collaborative member review
- Clinical expert validation sessions
- Implementation partner feedback integration
- Patient advocacy group input

### Standards Alignment
- HL7 FHIR community engagement
- CGM Implementation Guide coordination
- US Core profile alignment assessment
- International diabetes registry harmonization

## Success Metrics

### Coverage Targets
- **Variables**: 90%+ coverage of High priority elements
- **Coded Values**: 80%+ coverage of specification codes
- **Clinical Workflows**: 100% coverage of T1D Exchange core use cases

### Quality Measures
- Zero FHIR validation errors
- Complete example coverage for all profiles
- Comprehensive implementation guidance
- Automated testing suite with 95%+ pass rate

This roadmap ensures systematic completion of the T1D Exchange FHIR Implementation Guide while maintaining focus on clinical utility and implementation feasibility.